News & Updates

11-11-2021-PlinckFotografie -90.jpg

PhD candidate Maroussia Ganpat wins presenter award
September 2022

Maroussia participated in the “11th International Pediatric Renal Tumour Biology Conference”, where she presented her work on the establishment of a pediatric kidney tumor progression model to study SFPQ-TFE3 translocated Renal Cell Carcinoma. She has received the  award for best oral presentation.

11-11-2021-PlinckFotografie -87.jpg

New publication by Michael T. Meister of our sarcoma team
August 2022

Michael's paper describes the first collection of comprehensively characterized tumor organoid (tumoroid) models of pediatric rhabdomyosarcomas (RMS) as novel preclinical models for this highly aggressive pediatric cancer entity. You can read the paper here.

11-11-2021-PlinckFotografie -74.jpg

PhD candidate Irene Paassen appointed a travel grant
January 2022

Irene will participate in the conference "Organoids as tools for fundamental discovery and translation", where she will present her work on the establishment of an ATRT organoid model. She has received a Keystone Symposia Future of Science Fund scholarship to cover her travel expenses.

Screenshot 2022-02-10 at 11.09.47.png

The Drost website has launched!
January 2022

Our very own website is now online. Visit us for more details on our research, news and many more.


PhD candidate Lars Custers has successfully defended his thesis
October 2021

Warm congratulations to Lars for defending his thesis with title "From Derailed Development to Childhood Cancer: Using organoid models to study Malignant Rhabdoid Tumors​". 

11-11-2021-PlinckFotografie -2.jpg

NWO Vidi grant for Jarno Drost
July 2021

Jarno has been awarded the prestigious Vidi grant from the Dutch Research Council (NWO). He will receive €800,000 in research funding, which will be used to investigate the epigenetic landscape of childhood tumors.

"This is not only a very welcome appreciation for the research that we have worked so hard on in the past few years, but also enables us to further develop it and start new lines of research."